HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...

ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...

U.S. metropolitan areas have been identified as hot spots for hiring, job listings and talent migration, according to LinkedIn News’ “Cities on the Rise” list. Hospitals and health systems are among ...

With a deep background in research and years of senior care experience, Shadi Gholizadeh, PhD, uses her clinical know-how to drive TheKey to operational excellence.

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

Our Bureau, Mumbai Friday, July 18, 2025, 17:45 Hrs [IST] ...

Shares of Kymera KYMR have surged 70.7% in the past three months compared with the industry’s gain of 9.7%. The stock has ...

Sarepta Therapeutics, Inc. ( NASDAQ: SRPT) Strategic Restructure and ELEVIDYS Label Update Conference Call July 16, 2025 4:30 PM ET Douglas S. Ingram - President, CEO & Director Ian Estepan - ...

Viatris Chief R&D Officer Philippe Martin said, “Given that the study did not meet its objective for patients suffering from blepharitis, we are evaluating the appropriate next steps for the Phase 3 ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

The birth of eight three-parent babies in Britain has raised hopes for the future of mitochondrial donation. But in Australia big questions remain. It was the kind of radical reproductive technology ...

Spearheaded by the World Federation of Neurology, World Brain Day on July 22 will celebrate the theme of “Brain Health for ...